- Home
- PRME vs EP Comparison
PRME vs EP Comparison
Compare PRME & EP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- EP
- Stock Information
- Founded
- PRME 2019
- EP 1983
- Country
- PRME United States
- EP United States
- Employees
- PRME N/A
- EP N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- EP Oil & Gas Production
- Sector
- PRME Health Care
- EP Energy
- Exchange
- PRME Nasdaq
- EP Nasdaq
- Market Cap
- PRME 191.7M
- EP 151.2M
- IPO Year
- PRME 2022
- EP N/A
- Fundamental
- Price
- PRME $3.79
- EP $4.61
- Analyst Decision
- PRME Buy
- EP
- Analyst Count
- PRME 6
- EP 0
- Target Price
- PRME $8.88
- EP N/A
- AVG Volume (30 Days)
- PRME 4.8M
- EP 22.3K
- Earning Date
- PRME 08-07-2025
- EP 08-18-2025
- Dividend Yield
- PRME N/A
- EP N/A
- EPS Growth
- PRME N/A
- EP N/A
- EPS
- PRME N/A
- EP N/A
- Revenue
- PRME $4,961,000.00
- EP $42,796,178.00
- Revenue This Year
- PRME $126.92
- EP N/A
- Revenue Next Year
- PRME $87.32
- EP N/A
- P/E Ratio
- PRME N/A
- EP N/A
- Revenue Growth
- PRME 739.42
- EP 6.28
- 52 Week Low
- PRME $1.11
- EP $3.76
- 52 Week High
- PRME $5.17
- EP $8.12
- Technical
- Relative Strength Index (RSI)
- PRME 49.66
- EP 43.88
- Support Level
- PRME $3.51
- EP $4.32
- Resistance Level
- PRME $4.73
- EP $4.73
- Average True Range (ATR)
- PRME 0.39
- EP 0.32
- MACD
- PRME -0.13
- EP -0.04
- Stochastic Oscillator
- PRME 17.29
- EP 28.43
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the United States onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.